Susquehanna International Group, LLP Champions Oncology, Inc. Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
A detailed history of Susquehanna International Group, LLP transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 19,811 shares of CSBR stock, worth $134,516. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,811
Previous 33,930
41.61%
Holding current value
$134,516
Previous $250,000
49.6%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CSBR
# of Institutions
30Shares Held
5.69MCall Options Held
0Put Options Held
0-
Battery Management Corp. Boston, MA2.42MShares$16.4 Million2.99% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$11.6 Million0.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA333KShares$2.26 Million0.0% of portfolio
-
Tocqueville Asset Management L.P. New York, NY320KShares$2.17 Million0.03% of portfolio
-
Morgan Stanley New York, NY190KShares$1.29 Million0.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $91.8M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...